Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium for Neuroprotection in SCLC Patients Undergoing PCI
NCT01553916Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2012
- Primary completion
- Sep 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium carbonate in radiation-induced cognitive impairment (RICI), sponsored by Washington University School of Medicine. Started Apr 2012; status: completed.
02
Drugs
lithium carbonate
03
Conditions
radiation-induced cognitive impairment (RICI)
Beyond the preview
Go deeper on NCT01553916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01553916.